Disruption of genes encoding eIF4E binding proteins-1 and -2 does not alter basal or sepsis-induced changes in skeletal muscle protein synthesis in male or female mice

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Steiner, Jennifer L ^a   Pruznak, Anne M ^a   Deiter, Gina ^a   Navaratnarajah, Maithili ^a   Kutzler, Lydia ^a   Kimball, Scot R ^a   Lang, Charles H ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROGIN 1; INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN; INITIATION FACTOR 4E BINDING PROTEIN 1; INITIATION FACTOR 4E BINDING PROTEIN 2; INITIATION FACTOR 4G; INTERLEUKIN 6; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MUSCLE RING FINGER 1 PROTEIN; S6 KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CARRIER PROTEIN; EEF2K PROTEIN, MOUSE; EIF4EBP1 PROTEIN, MOUSE; EIF4EBP2 PROTEIN, MOUSE; ELONGATION FACTOR 2 KINASE; FBXO32 PROTEIN, MOUSE; INITIATION FACTOR; MTOR PROTEIN, MOUSE; MUSCLE PROTEIN; PHOSPHOPROTEIN; RPS6KA1 PROTEIN, MOUSE; TARGET OF RAPAMYCIN KINASE; TRIM63 PROTEIN, MOUSE; UBIQUITIN PROTEIN LIGASE;

4E BP1 GENE; 4E BP2 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCATION; INFLAMMATION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; S6K1 GENE; SEPSIS; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WILD TYPE; ANIMAL; DEFICIENCY; GENE DELETION; GENETICS; HEART MUSCLE; LIVER; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

ANIMALS; CARRIER PROTEINS; ELONGATION FACTOR 2 KINASE; EUKARYOTIC INITIATION FACTORS; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; INTERLEUKIN-6; LIVER; MALE; MICE; MICE, KNOCKOUT; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOCARDIUM; PHOSPHOPROTEINS; PHOSPHORYLATION; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SEPSIS; SIGNAL TRANSDUCTION; SKP CULLIN F-BOX PROTEIN LIGASES; TOR SERINE-THREONINE KINASES; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN-PROTEIN LIGASES;

EID: 84903398762     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099582     Document Type: Article

References (45)

1. Hill GL (1998) Implications of critical illness, injury, and sepsis on lean body mass and nutritional needs. Nutrition 14: 557-558.
2. Jeschke MG, Chinkes DL, Finnerty CC, Kulp G, Suman OE, et al. (2008) Pathophysiologic response to severe burn injury. Ann Surg 248: 387-401.
3. Blackburn GL, Bistrian BR (1976) Nutritional care of the injured and/or septic patient. Surg Clin North Am 56: 1195-1224.
4. Callahan LA, Supinski GS (2009) Sepsis-induced myopathy. Crit Care Med 37: S354-367.
5. Thibault R, Cano N, Pichard C (2011) Quantification of lean tissue losses during cancer and HIV infection/AIDS. Curr Opin Clin Nutr Metab Care 14: 261-267.
6. Kumar NB, Kazi A, Smith T, Crocker T, Yu D, et al. (2010) Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment. Curr Treat Options Oncol 11: 107-117.
7. Smith IJ, Lecker SH, Hasselgren PO (2008) Calpain activity and muscle wasting in sepsis. Am J Physiol Endocrinol Metab 295: E762-771.
8. Frost RA, Lang CH (2011) mTor signaling in skeletal muscle during sepsis and inflammation: where does it all go wrong? Physiology (Bethesda) 26: 83-96.
9. Lang CH, Frost RA (2006) Glucocorticoids and TNFalpha interact cooperatively to mediate sepsis-induced leucine resistance in skeletal muscle. Mol Med 12: 291-299. (Pubitemid 46489822)
10. Zhai L, Messina JL (2009) Age and tissue specific differences in the development of acute insulin resistance following injury. J Endocrinol 203: 365-374.
11. Hong-Brown LQ, Brown CR, Cooney RN, Frost RA, Lang CH (2003) Sepsis-induced muscle growth hormone resistance occurs independently of STAT5 phosphorylation. Am J Physiol Endocrinol Metab 285: E63-72. (Pubitemid 36736362)
12. Kazi AA, Pruznak AM, Frost RA, Lang CH (2011) Sepsis-induced alterations in protein-protein interactions within mTOR complex 1 and the modulating effect of leucine on muscle protein synthesis. Shock 35: 117-125.
13. Lang CH, Frost RA, Bronson SK, Lynch CJ, Vary TC (2010) Skeletal muscle protein balance in mTOR heterozygous mice in response to inflammation and leucine. Am J Physiol Endocrinol Metab 298: E1283-1294.
14. Frost RA, Pereyra E, Lang CH (2011) Ethyl pyruvate preserves IGF-I sensitivity toward mTOR substrates and protein synthesis in C2C12 myotubes. Endocrinology 152: 151-163.
15. Frost RA, Nystrom GJ, Lang CH (2009) Endotoxin and interferon-gamma inhibit translation in skeletal muscle cells by stimulating nitric oxide synthase activity. Shock 32: 416-426.
16. Lang CH, Frost RA (2007) Sepsis-induced suppression of skeletal muscle translation initiation mediated by tumor necrosis factor alpha. Metabolism 56: 49-57. (Pubitemid 44855012)
17. Lang CH, Pruznak AM, Frost RA (2005) TNFalpha mediates sepsis-induced impairment of basal and leucine-stimulated signaling via S6K1 and eIF4E in cardiac muscle. J Cell Biochem 94: 419-431. (Pubitemid 41420318)
18. Lang CH, Fan J, Cooney R, Vary TC (1996) IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis. Am J Physiol 270: E430-437.
19. Constantin D, McCullough J, Mahajan RP, Greenhaff PL (2011) Novel events in the molecular regulation of muscle mass in critically ill patients. J Physiol 589: 3883-3895.
20. Jewell JL, Guan KL (2013) Nutrient signaling to mTOR and cell growth. Trends Biochem Sci 38: 233-242.
21. von Manteuffel SR, Dennis PB, Pullen N, Gingras AC, Sonenberg N, et al. (1997) The insulin-induced signalling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70s6k. Mol Cell Biol 17: 5426-5436. (Pubitemid 27357640)
22. Le Bacquer O, Petroulakis E, Paglialunga S, Poulin F, Richard D, et al. (2007) Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. J Clin Invest 117: 387-396. (Pubitemid 46203967)
23. Tsukiyama-Kohara K, Poulin F, Kohara M, DeMaria CT, Cheng A, et al. (2001) Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat Med 7: 1128-1132. (Pubitemid 33010021)
24. Poulin F, Gingras AC, Olsen H, Chevalier S, Sonenberg N (1998) 4E-BP3, a new member of the eukaryotic initiation factor 4E-binding protein family. J Biol Chem 273: 14002-14007. (Pubitemid 28268456)
25. Pause A, Belsham GJ, Gingras AC, Donze O, Lin TA, et al. (1994) Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function. Nature 371: 762-767.
26. Haghighat A, Mader S, Pause A, Sonenberg N (1995) Repression of cap-dependent translation by 4E-binding protein 1: competition with p220 for binding to eukaryotic initiation factor-4E. EMBO J 14: 5701-5709.
27. Gingras AC, Kennedy SG, O'Leary MA, Sonenberg N, Hay N (1998) 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev 12: 502-513. (Pubitemid 28101013)
28. Lang CH, Lynch CJ, Vary TC (2010) BCATm deficiency ameliorates endotoxin-induced decrease in muscle protein synthesis and improves survival in septic mice. Am J Physiol Regul Integr Comp Physiol 299: R935-944.
29. Nystrom G, Pruznak A, Huber D, Frost RA, Lang CH (2009) Local insulin-like growth factor I prevents sepsis-induced muscle atrophy. Metabolism 58: 787-797.
30. Nystrom GJ, Lang CH (2008) Sepsis and AMPK Activation by AICAR Differentially Regulate FoxO-1, -3 and -4 mRNA in Striated Muscle. Int J Clin Exp Med 1: 50-63.
31. Demers G, Griffin G, De Vroey G, Haywood JR, Zurlo J, et al. (2006) Animal research. Harmonization of animal care and use guidance. Science 312: 700-701.
32. Lang SM, Kazi AA, Hong-Brown L, Lang CH (2012) Delayed recovery of skeletal muscle mass following hindlimb immobilization in mTOR heterozygous mice. PLoS One 7: e38910.
33. Albaugh VL, Judson JG, She P, Lang CH, Maresca KP, et al. (2011) Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis. Mol Psychiatry 16: 569-581.
34. Vary TC, Lang CH (2008) Assessing effects of alcohol consumption on protein synthesis in striated muscles. Methods Mol Biol 447: 343-355.
35. Huang BP, Wang Y, Wang X, Wang Z, Proud CG (2009) Blocking eukaryotic initiation factor 4F complex formation does not inhibit the mTORC1-dependent activation of protein synthesis in cardiomyocytes. Am J Physiol Heart Circ Physiol 296: H505-514.
36. Dennis MD, Jefferson LS, Kimball SR (2012) Role of p70S6K1-mediated phosphorylation of eIF4B and PDCD4 proteins in the regulation of protein synthesis. J Biol Chem 287: 42890-42899.
37. Browne GJ, Proud CG (2004) A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin. Mol Cell Biol 24: 2986-2997. (Pubitemid 38381287)
38. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, et al. (2001) Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708. (Pubitemid 33104839)
39. Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M (2013) Mechanisms regulating skeletal muscle growth and atrophy. FEBS J 280: 4294-4314.
40. Frost RA, Lang CH (2007) Protein kinase B/Akt: a nexus of growth factor and cytokine signaling in determining muscle mass. J Appl Physiol (1985) 103: 378-387.
41. Phillips SM, Glover EI, Rennie MJ (2009) Alterations of protein turnover underlying disuse atrophy in human skeletal muscle. J Appl Physiol (1985) 107: 645-654.
42. Frost RA, Nystrom GJ, Jefferson LS, Lang CH (2007) Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle. Am J Physiol Endocrinol Metab 292: E501-512. (Pubitemid 46220575)
43. Fortin CF, Cloutier A, Ear T, Sylvain-Prevost S, Mayer TZ, et al. (2011) A class IA PI3K controls inflammatory cytokine production in human neutrophils. Eur J Immunol 41: 1709-1719.
44. Yang HS, Cho MH, Zakowicz H, Hegamyer G, Sonenberg N, et al. (2004) A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Biol 24: 3894-3906. (Pubitemid 38496167)
45. Nielsen KH, Behrens MA, He Y, Oliveira CL, Jensen LS, et al. (2011) Synergistic activation of eIF4A by eIF4B and eIF4G. Nucleic Acids Res 39: 2678-2689.